Nurix Therapeutics’ $160.4 Million Follow-on Offering

Davis Polk advised the joint book-running managers and representatives of the several underwriters in the offering.Nurix Therapeutics, Inc. completed its follow-on offering of 5,175,000 shares of…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here